- ¥476bn
- ¥1tn
- ¥1tn
- 35
- 79
- 78
- 73
Annual income statement for Lixil, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,514,449 | 1,378,255 | 1,428,578 | 1,495,987 | 1,483,224 |
Cost of Revenue | |||||
Gross Profit | 502,626 | 469,220 | 486,869 | 468,625 | 472,712 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,469,129 | 1,346,492 | 1,358,025 | 1,470,678 | 1,466,230 |
Operating Profit | 45,320 | 31,763 | 70,553 | 25,309 | 16,994 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40,909 | 33,804 | 67,262 | 19,759 | 6,664 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27,727 | 16,368 | 50,540 | 16,888 | -9,455 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 12,518 | 33,048 | 48,603 | 15,991 | -13,908 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12,752 | 33,196 | 48,740 | 15,991 | -13,908 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 102 | 96.7 | 150 | 55.6 | -3.63 |
Dividends per Share |